Anticoagulation to prevent disease progression in patients with cirrhosis

Affiliations

¹ Surgical Research Laboratory, Section of Hepatobiliary Surgery and Liver Transplantation Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.a.lisman@umcg.nl.
² Liver Intensive Therapy Unit, Institute of Liver Studies, Kings College Hospital, Denmark Hill, London, SE5 9RS, UK.
³ Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.

Comment

Ton Lisman et al. J Hepatol. 2023 Sep.

. 2023 Sep;79(3):e123-e124.

doi: 10.1016/j.jhep.2023.03.022. Epub 2023 Mar 30.

¹ Surgical Research Laboratory, Section of Hepatobiliary Surgery and Liver Transplantation Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.a.lisman@umcg.nl.
² Liver Intensive Therapy Unit, Institute of Liver Studies, Kings College Hospital, Denmark Hill, London, SE5 9RS, UK.
³ Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.

No abstract available

Comment in

Reply to: "Anticoagulation to prevent disease progression in patients with cirrhosis".
Albillos A, Guerrero A, Téllez L. Albillos A, et al. J Hepatol. 2023 Sep;79(3):e125-e126. doi: 10.1016/j.jhep.2023.05.040. Epub 2023 Jun 9. J Hepatol. 2023. PMID: 37301265 No abstract available.

Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A; Baveno Cooperation: an EASL consortium. Guerrero A, et al. J Hepatol. 2023 Jul;79(1):69-78. doi: 10.1016/j.jhep.2023.02.023. Epub 2023 Feb 28. J Hepatol. 2023. PMID: 36858157